There are many ways to generate antibodies, but sometimes traditional methods don’t deliver what you need.

Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance

Anti-aging company – Five Alarm Bio – reveal their discoveries on safe and effective treatments for age-associated diseases and disabilities

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

An insight into the research fuelling developments for universal cancer immunotherapies

Understanding the role of microbial fermentation in the production of mRNA vaccines.